Analyzing the immune biomarkers and immune infiltration in The Cancer Genome Atlas (TCGA)-NSCLC and the Gene Expression Omnibus (GEO) cohorts, the investigators noted significant PFS improvement subsequent to ubiquitin protein ligase E3A (UBE3A) erasure. This evidence concerns the gene UBE3A and non-small cell lung carcinoma.